Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SMS Pharmaceuticals Ltd Call Transcript 2024

Aug 3, 2024

62302_rns_2024-08-03_417f32b4-cd6e-4817-b1b2-16614d825c1d.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [240 x 160] intentionally omitted <==

Date: 03[rd] August, 2024

To The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001.

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Intimation of Investor’s Conference Call

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing here with invitation for Investor’s Conference Call, scheduled to be held on Wednesday, 07[th] August, 2024 at 11:00 AM, IST, to discuss the Company’s financial performance for the quarter ended 30[th] June, 2024.

Please take into your records

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMA Digitally signed by THIRUMALESH LESH TUMMA Date: 2024.08.03 TUMMA 19:16:52 +05'30' Thirumalesh Tumma Company Secretary

==> picture [144 x 71] intentionally omitted <==

Hyderabad, August 5, 2024: SMS Pharmaceuticals Ltd, a diversified and integrated pharmaceutical company specialising in APIs and intermediates, will announce its results for the first quarter ended June 30, 2024, on Monday, August 05, 2024.

The results will also be available on the Company’s website, www.smspharma.com. The company will hold an earnings conference on Wednesday, August 07, at 11.00 am IST, where senior management will discuss its results and performance.

SMS Pharmaceuticals Q1 FY 2025 Earnings Call on Wednesday, August 07, 2024, at 11.00 am (IST)

Conference Dial-In Information:

Diamond Pass : Please click here to please pre-register for the call

+91 22 6280 1260 Primary Number: +91 22 7115 8197 Hongkong – 800964448 Singapore – 8001012045 Toll Free Number: UK – 08081011573 US – 18667462133

For any further information, please contact:

Investor Relations: EQSPONENT Partners LLP Aditya Dutta M. +91 98187 39589